. 1983 Dec;25(4):823-9.

[The effect of osteoclast-activating factor (OAF) on the absorption of alveolar bone. II. Participation of the monocyte to OAF-producing cells]

[Article in Japanese]

[Article in Japanese]

Y Marumoto et al. Nihon Shishubyo Gakkai Kaishi. 1983 Dec.

. 1983 Dec;25(4):823-9.

No abstract available

Similar articles

[The effects of osteoclast-activating factor (OAF) on the absorption of alveolar bone. 1. Production and purification of OAF (author's transl)].
Marumoto Y, Kusunoki K, Fijihashi H, Osaka H, Nakamura Y, Ikeda K. Marumoto Y, et al. Nihon Shishubyo Gakkai Kaishi. 1982 Mar;24(1):121-7. Nihon Shishubyo Gakkai Kaishi. 1982. PMID: 6980245 Japanese. No abstract available.
Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes.
Chen P, Trummel C, Horton J, Baker JJ, Oppenheim JJ. Chen P, et al. Eur J Immunol. 1976 Oct;6(10):732-6. doi: 10.1002/eji.1830061014. Eur J Immunol. 1976. PMID: 797286
[Biochemistry of alveolar resorption and regeneration].
Shimizu M, Henmi M. Shimizu M, et al. Nihon Shika Ishikai Zasshi. 1985 Dec;38(9):905-10. Nihon Shika Ishikai Zasshi. 1985. PMID: 3869166 Japanese. No abstract available.
[Osteoclast activating factor (OAF)].
Kamihagi K, Katayama M, Kato I. Kamihagi K, et al. Nihon Rinsho. 1995 Mar;53 Su Pt 2:756-8. Nihon Rinsho. 1995. PMID: 8753352 Review. Japanese. No abstract available.
Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K. Väänänen K. Adv Drug Deliv Rev. 2005 May 25;57(7):959-71. doi: 10.1016/j.addr.2004.12.018. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15876398 Review.